HONTECILLAS RAQUEL enters LANDOS BIOPHARMA, INC. with 182.49K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 2/3/2021ACC: 0001209191-21-007453
Officer· Chief Scientific Officer
Since Feb 2021
182.49K
Baseline shares
0.00
Direct ownership
0 positions
182.49K
Derivative underlying
1 instrument
1
Security positions
182.49K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned182.49K
Total
182.49K indirect182.49K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 182.49K | Indirect |
| Total | 182.49K | 182.49K indirect |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
182.49K
Shares owned
N/A
Exercise price
1.86
Expiration
—
Exercise window
—
Total
Underlying
182.49K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 1.86 | — | — | 182.49K | N/A |
| Total | 182.49K | 0.00 | ||||